Figure 3.
NRM and REL cumulative incidence estimates (36-month) from a competing risk model, estimated separately for both conditioning regimens (standard myeloablative and RIC) and 2 age classes (≤ 50 years and > 50 years).
NRM and REL cumulative incidence estimates (36-month) from a competing risk model, estimated separately for both conditioning regimens (standard myeloablative and RIC) and 2 age classes (≤ 50 years and > 50 years).
